Desitin Arzneimittel Gmbh
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Private
- Established
- 1919-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.desitin.de
Clinical Trials
20
Active:8
Completed:11
Trial Phases
3 Phases
Phase 1:10
Phase 2:1
Phase 3:2
Drug Approvals
4
CIMA_AEMPS:4
Drug Approvals
FAMPRIDINA DESITIN 10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
TERIFLUNOMIDA DESITIN 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (76.9%)Phase 3
2 (15.4%)Phase 2
1 (7.7%)Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets
Phase 1
Completed
- Conditions
- Multiple Drug Use
- Interventions
- Drug: Sodium valproate 500 MGDrug: Valproic Acid 500 MG
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 22
- Registration Number
- NCT06214130
- Locations
- 🇨🇦
Biopharma Services INC, Toronto, Canada
Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 28
- Registration Number
- NCT06211283
- Locations
- 🇨🇦
Biopharma Services INC, Toronto, Canada
Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT06199791
- Locations
- 🇨🇦
Biopharma Services INC, Toronto, Canada
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
- First Posted Date
- 2022-02-11
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 298
- Registration Number
- NCT05236842
- Locations
- 🇧🇪
Pneumocare SRL, Namur, Belgium
Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
Phase 1
Completed
- Conditions
- Fasted State
- Interventions
- First Posted Date
- 2014-04-17
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 12
- Registration Number
- NCT02116465
- Locations
- 🇧🇬
Department of Clinical Pharmacology, Sofia, Bulgaria
- Prev
- 1
- 2
- 3
- Next
News
No news found